IBRX vs GPGI Comparison

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

GPGI Inc is a diversified holding platform comprising businesses operating in multiple industries. The platform focuses on acquiring, owning, and scaling operating companies. It currently includes CompoSecure and Husky Technologies. CompoSecure provides technology and manufacturing solutions related to metal payment cards, security, and authentication. Its products and services are used by financial institutions, fintech companies, and other customers. Husky designs and manufactures industrial equipment and provides aftermarket services. Its equipment is used in the production of plastic products, including beverage and food containers, medical devices, and consumer electronics components.